Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review
- PMID: 21466501
- PMCID: PMC3154701
- DOI: 10.2174/1874473711104010028
Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review
Abstract
The diversion, misuse, and non-medically supervised use of buprenorphine and buprenorphine/naloxone by opioid users are reviewed. Buprenorphine and buprenorphine/naloxone are used globally as opioid analgesics and in the treatment of opioid dependency. Diversion of buprenorphine and buprenorphine/naloxone represents a complex medical and social issue, and has been widely documented in various geographical regions throughout the world. We first discuss the clinical properties of buprenorphine and its abuse potential. Second, we discuss its diversion and illicit use on an international level, as well as motivations for those activities. Third, we examine the medical risks and benefits of buprenorphine's non-medically supervised use and misuse. These risks and benefits include the effect of buprenorphine's use on HIV risk and the risk of its concomitant use with other medications and drugs of abuse. Finally, we discuss the implications of diversion, misuse, and non-medically supervised use (including potential measures to address issues of diversion); and potential areas for further research.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
From research to the real world: buprenorphine in the decade of the Clinical Trials Network.J Subst Abuse Treat. 2010 Jun;38 Suppl 1(Suppl 1):S53-60. doi: 10.1016/j.jsat.2010.01.009. J Subst Abuse Treat. 2010. PMID: 20307796 Free PMC article.
-
The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence.Expert Opin Pharmacother. 2009 Oct;10(15):2537-44. doi: 10.1517/14656560903213405. Expert Opin Pharmacother. 2009. PMID: 19708849 Review.
-
Time to include buprenorphine-naloxone combination in the WHO Model List of Essential Medicines.J Opioid Manag. 2013 Jul-Aug;9(4):237. J Opioid Manag. 2013. PMID: 24380101 No abstract available.
-
Buprenorphine for human immunodeficiency virus/hepatitis C virus-coinfected patients: does it serve as a bridge to hepatitis C virus therapy?J Addict Med. 2012 Sep;6(3):179-85. doi: 10.1097/ADM.0b013e318257377f. J Addict Med. 2012. PMID: 22614935 Free PMC article.
-
Buprenorphine and naloxone for heroin dependence.Curr Psychiatry Rep. 2000 Dec;2(6):519-26. doi: 10.1007/s11920-000-0012-8. Curr Psychiatry Rep. 2000. PMID: 11123005 Review.
Cited by
-
"You are not clean until you're not on anything": Perceptions of medication-assisted treatment in rural Appalachia.Int J Drug Policy. 2020 Nov;85:102704. doi: 10.1016/j.drugpo.2020.102704. Epub 2020 Mar 12. Int J Drug Policy. 2020. PMID: 32173274 Free PMC article.
-
On my own terms: Motivations for self-treating opioid-use disorder with non-prescribed buprenorphine.Drug Alcohol Depend. 2020 May 1;210:107958. doi: 10.1016/j.drugalcdep.2020.107958. Epub 2020 Mar 16. Drug Alcohol Depend. 2020. PMID: 32203863 Free PMC article.
-
Toward a systematic approach to opioid rotation.J Pain Res. 2014 Oct 17;7:589-608. doi: 10.2147/JPR.S55782. eCollection 2014. J Pain Res. 2014. PMID: 25378948 Free PMC article. Review.
-
Advances in the delivery of buprenorphine for opioid dependence.Drug Des Devel Ther. 2017 Aug 28;11:2493-2505. doi: 10.2147/DDDT.S72543. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28894357 Free PMC article. Review.
-
Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France.Harm Reduct J. 2021 Jan 19;18(1):11. doi: 10.1186/s12954-021-00460-0. Harm Reduct J. 2021. PMID: 33468133 Free PMC article.
References
-
- United Nations Office on Drugs and Crime. World Drug Report. 2007.
-
- World Health Organization. WHO Drug Information. 3. Vol. 19. 2005. p. 72.
-
- World Health Organization, Office on Drugs and Crime. Drug Report. 2007.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical